Segment disclosures

Company overview

SOLVENTUM CORPORATION

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

14 dimension combinations 150 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Dental Solutions Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:DentalSolutionsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30396000000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30750000000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31354000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-311349000000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30340000000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301006000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30338000000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30667000000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31328000000 USD20260505Open filing evidence
2024-01-01 – 2024-12-311295000000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30313000000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30979000000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30331000000 USD20250808Open filing evidence
2024-01-01 – 2024-06-30666000000 USD20250808Open filing evidence
2024-01-01 – 2024-03-31335000000 USD20250509Open filing evidence
2023-01-01 – 2023-12-311329000000 USD20260227Open filing evidence
2023-07-01 – 2023-09-30331000000 USD20241108Open filing evidence
2023-01-01 – 2023-09-301023000000 USD20241108Open filing evidence
2023-04-01 – 2023-06-30351000000 USD20240809Open filing evidence
2023-01-01 – 2023-06-30692000000 USD20240809Open filing evidence
2023-01-01 – 2023-03-31341000000 USD20240510Open filing evidence
2022-01-01 – 2022-12-311327000000 USD20250228Open filing evidence

Operating Segments · Health Information Systems Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:HealthInformationSystemsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30354000000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30696000000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31342000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-311360000000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30345000000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301012000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30339000000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30667000000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31329000000 USD20260505Open filing evidence
2024-01-01 – 2024-12-311306000000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30326000000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30971000000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30328000000 USD20250808Open filing evidence
2024-01-01 – 2024-06-30645000000 USD20250808Open filing evidence
2024-01-01 – 2024-03-31317000000 USD20250509Open filing evidence
2023-01-01 – 2023-12-311285000000 USD20260227Open filing evidence
2023-07-01 – 2023-09-30321000000 USD20241108Open filing evidence
2023-01-01 – 2023-09-30953000000 USD20241108Open filing evidence
2023-04-01 – 2023-06-30316000000 USD20240809Open filing evidence
2023-01-01 – 2023-06-30632000000 USD20240809Open filing evidence
2023-01-01 – 2023-03-31316000000 USD20240510Open filing evidence
2022-01-01 – 2022-12-311227000000 USD20250228Open filing evidence

Operating Segments · Med Surg Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301372000000 USD20260805Open filing evidence
2026-01-01 – 2026-06-302607000000 USD20260805Open filing evidence
2026-01-01 – 2026-03-311234000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-314817000000 USD20260227Open filing evidence
2025-07-01 – 2025-09-301206000000 USD20251106Open filing evidence
2025-01-01 – 2025-09-303581000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-301218000000 USD20260805Open filing evidence
2025-01-01 – 2025-06-302375000000 USD20260805Open filing evidence
2025-01-01 – 2025-03-311157000000 USD20260505Open filing evidence
2024-01-01 – 2024-12-314637000000 USD20260227Open filing evidence
2024-07-01 – 2024-09-301182000000 USD20251106Open filing evidence
2024-01-01 – 2024-09-303463000000 USD20251106Open filing evidence
2024-04-01 – 2024-06-301162000000 USD20250808Open filing evidence
2024-01-01 – 2024-06-302281000000 USD20250808Open filing evidence
2024-01-01 – 2024-03-311119000000 USD20250509Open filing evidence
2023-01-01 – 2023-12-314632000000 USD20260227Open filing evidence
2023-07-01 – 2023-09-301180000000 USD20241108Open filing evidence
2023-01-01 – 2023-09-303464000000 USD20241108Open filing evidence
2023-04-01 – 2023-06-301161000000 USD20240809Open filing evidence
2023-01-01 – 2023-06-302284000000 USD20240809Open filing evidence
2023-01-01 – 2023-03-311123000000 USD20240510Open filing evidence
2022-01-01 – 2022-12-314585000000 USD20250228Open filing evidence

Operating Segments · Med Surg Segment · Advanced Wound Care

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:AdvancedWoundCareMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31448000000 USD20250509Open filing evidence
2024-01-01 – 2024-03-31441000000 USD20250509Open filing evidence

Operating Segments · Med Surg Segment · Infection Prevention And Surgical Solutions

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:InfectionPreventionAndSurgicalSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31710000000 USD20250509Open filing evidence
2024-01-01 – 2024-03-31678000000 USD20250509Open filing evidence

Operating Segments · Purification And Filtration Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:PurificationAndFiltrationSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-03-310 USD20260505Open filing evidence
2025-01-01 – 2025-12-31497000000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30128000000 USD20251106Open filing evidence
2025-01-01 – 2025-09-30497000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30189000000 RestatedUSD20260805Open filing evidence
2025-01-01 – 2025-06-30369000000 RestatedUSD20260805Open filing evidence
2025-01-01 – 2025-03-31180000000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-31709000000 RestatedUSD20260227Open filing evidence
2024-07-01 – 2024-09-30180000000 RestatedUSD20251106Open filing evidence
2024-01-01 – 2024-09-30532000000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-06-30238000000 USD20250808Open filing evidence
2024-01-01 – 2024-06-30483000000 USD20250808Open filing evidence
2024-01-01 – 2024-03-31245000000 USD20250509Open filing evidence
2023-01-01 – 2023-12-31689000000 RestatedUSD20260227Open filing evidence
2023-07-01 – 2023-09-30242000000 USD20241108Open filing evidence
2023-01-01 – 2023-09-30721000000 USD20241108Open filing evidence
2023-04-01 – 2023-06-30248000000 USD20240809Open filing evidence
2023-01-01 – 2023-06-30479000000 USD20240809Open filing evidence
2023-01-01 – 2023-03-31231000000 USD20240510Open filing evidence
2022-01-01 – 2022-12-31991000000 USD20250228Open filing evidence

Operating Segments · Advanced Wound Care · Med Surg Segment

Consolidation Items · Subsegments · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=solv:AdvancedWoundCareMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-31497000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-311883000000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30485000000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301400000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30467000000 USD20250808Open filing evidence
2025-01-01 – 2025-06-30915000000 USD20250808Open filing evidence
2025-01-01 – 2025-03-31448000000 USD20260505Open filing evidence
2024-01-01 – 2024-12-311835000000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30468000000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301369000000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30460000000 USD20250808Open filing evidence
2024-01-01 – 2024-06-30901000000 USD20250808Open filing evidence
2023-01-01 – 2023-12-311826000000 USD20260227Open filing evidence

Operating Segments · Infection Prevention And Surgical Solutions · Med Surg Segment

Consolidation Items · Subsegments · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=solv:InfectionPreventionAndSurgicalSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-31737000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-312934000000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30722000000 USD20251106Open filing evidence
2025-01-01 – 2025-09-302182000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30750000000 USD20250808Open filing evidence
2025-01-01 – 2025-06-301460000000 USD20250808Open filing evidence
2025-01-01 – 2025-03-31710000000 USD20260505Open filing evidence
2024-01-01 – 2024-12-312802000000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30713000000 USD20251106Open filing evidence
2024-01-01 – 2024-09-302093000000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30702000000 USD20250808Open filing evidence
2024-01-01 – 2024-06-301380000000 USD20250808Open filing evidence
2023-01-01 – 2023-12-312805000000 USD20260227Open filing evidence

Dental Solutions Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=solv:DentalSolutionsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30317000000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301067000000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30340000000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301006000000 USD20261105Open filing evidence

Health Information Systems Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=solv:HealthInformationSystemsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30356000000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301052000000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30345000000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301012000000 USD20261105Open filing evidence

Med Surg Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301211000000 USD20261105Open filing evidence
2026-01-01 – 2026-09-303818000000 USD20261105Open filing evidence
2025-07-01 – 2025-09-301206000000 USD20261105Open filing evidence
2025-01-01 – 2025-09-303581000000 USD20261105Open filing evidence

Med Surg Segment · Advanced Wound Care · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:AdvancedWoundCareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30528000000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301561000000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30537000000 USD20260805Open filing evidence
2026-01-01 – 2026-06-301034000000 USD20260805Open filing evidence
2025-07-01 – 2025-09-30485000000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301400000000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30467000000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30915000000 USD20260805Open filing evidence

Med Surg Segment · Infection Prevention And Surgical Solutions · Operating Segments

Statement Business Segments · Subsegments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:InfectionPreventionAndSurgicalSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30683000000 USD20261105Open filing evidence
2026-01-01 – 2026-09-302256000000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30836000000 USD20260805Open filing evidence
2026-01-01 – 2026-06-301573000000 USD20260805Open filing evidence
2025-07-01 – 2025-09-30722000000 USD20261105Open filing evidence
2025-01-01 – 2025-09-302182000000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30750000000 USD20260805Open filing evidence
2025-01-01 – 2025-06-301460000000 USD20260805Open filing evidence

Purification And Filtration Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=solv:PurificationAndFiltrationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD20261105Open filing evidence
2026-01-01 – 2026-09-300 USD20261105Open filing evidence
2025-07-01 – 2025-09-30128000000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30497000000 USD20261105Open filing evidence